I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ARVO 2022

-
Coming soon
11:42 AM
Duration 10mins Virtual
Prediction of Proliferative Diabetic Retinopathy (PDR) from Nonproliferative Diabetic Retinopathy (NPDR) Using Real-world (RW) Electronic Health Record (EHR) Data
Babiuch A, Yang Q, Damopoulos D, Rizzo S,Valentim C, Wu A, Benmansour F, Luu J, Kalur A, Sastry R, Iyer A, Muste J, Spicer G, Ferrara D, Singh R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:30 PM
Duration 10mins Four Seasons Blrm 1
Development and Validation of Prognostic Models to Increase Power of Clinical Trials for Geographic Atrophy (GA)
Steffen V, Anegondi N, Yang Q, Friesenhahn M, Ferrara D, Gao S, Rabe C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:21 AM
Duration 10mins Four Seasons Blrm 1
Quantification of Lesion Size Progression of Incomplete and Complete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration
Schmitz-Valckenberg S, Sassmannshausen M, Braun M, Steffen V, Gao S, Honigberg L, Ferrara D, Pfau M, Holz F

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:47 PM
Duration 10mins Room: 205/207
Efficacy, durability, and safety of faricimab in diabetic macular edema: 2-year results from the phase 3 YOSEMITE and RHINE trials
Lim JI, Wells JA, Eichenbaum DA, Danzig C, Asik K, Haskova Z, Mohan S, Silverman D, Tang Y, Lin H

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:04 PM
Duration 10mins Room: 205/207
Faricimab in neovascular age-related macular degeneration: updated week 48 efficacy, safety, and durability in the phase 3 TENAYA and LUCERNE trials
London N, Guymer R, Demetriades AM, Quezada Ruiz C, Silverman D, Ives J, Basu K, Lin H

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:21 PM
Duration 10mins Virtual
Archway phase 3 trial of the Port Delivery System with ranibizumab (PDS) for neovascular AMD: end-of-study results
Mittra R, Brooks L, Wykoff C, Callaway N, DeGraaf S, Fung AE, Gune S, LePogam S, Smith R, Willis J, Barteselli G

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:30 PM
Duration 10mins Room: 2B/3B
Use of collagen-hybridizing peptides to assess active fibrosis in two mouse models of choroidal neovascularization
Westenskow P, Bennink L, Foxton R, Kirkness M, Linder M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:04 PM
Duration 10mins Virtual
Personalized treatment interval (PTI) dosing dynamics over 2 years in the phase 3 YOSEMITE and RHINE trials of faricimab in diabetic macular edema
Baumal CR, Kitchens JW, Jaffe GJ, Gerendas BS, Abreu F, Asik K, Camino A, Jain N, Haskova Z

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:38 PM
Duration 10mins Four Seasons Blrm 1
Feature Discovery Using Ablation Studies for Deep Learning–Based Geographic Atrophy (GA) Progression Prediction
Cluceru J, Anegondi N, Yang Q, Steffen V, Rabe C, Friesenhahn M, Ferrara D, Gao S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:17 PM
Duration 10mins Room: 1EF Mile High Blrm (Denver Convention Center)
Aqueous humor vascular endothelial growth factor pharmacodynamics in the phase 3 Archway trial of the Port Delivery System with ranibizumab
Adam M, Barras L, Maia M, Gune S, Maass K, Chang M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar